Alpha 2.0
Login Register
» Authors » Angelo Platania

Angelo Platania

Explore the profile of Angelo Platania including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 42
Followers 0
Related Specialties
Oncology
General Medicine
Top 10 Co-Authors
Anna Santacaterina
Stefano Pergolizzi
Silvana Parisi
Alberto Cacciola
Antonio Pontoriero
Sara Lillo
Giuseppe Iati
Pietro Delia
Consuelo Tamburella
Nicola Settineri
Published In
Tumori
Crit Rev Oncol Hematol
Radiol Med
Rep Pract Oncol Radiother
Heliyon
Affiliations
Soon will be listed here.
Recent Articles
1.
Navigating chemotherapy and immunotherapy in early-stage lung cancer. A critical review and statements from INTERACTION group
Catania C, Proto C, Bennati C, Grisanti S, Colantonio I, Petrella F, et al.
Crit Rev Oncol Hematol . 2025 Feb; 208:104633. PMID: 39900317
Introduction: During the recent INTERACTION group congress held on February 16-17, 2024, in Milan, Italy, many aspects of early-stage lung cancer treatment were explored. This review delves into perioperative treatment,...
2.
[Concurrent simultaneous integrated boost radiotherapy and cetuximab in head and neck squamous cell cancer patients: is it feasible in daily clinical practice?]
Chillari F, Parisi S, Ferrantelli G, Carrubba C, Santacaterina A, Critelli P, et al.
Recenti Prog Med . 2024 May; 115(5):1e-6e. PMID: 38708539
Introduction And Aim: Locally advanced head and neck squamous cell carcinoma (LA-Hnscc) is a true therapeutical challenge in the modern era and the scientific community is trying to face this...
3.
New options and open issues in the management of unresectable stage III and in early-stage NSCLC: A report from an expert panel of Italian medical and radiation oncologists - INTERACTION group
Catania C, Filippi A, Sangalli C, Piperno G, Russano M, Greco C, et al.
Crit Rev Oncol Hematol . 2023 Aug; 190:104108. PMID: 37633350
Importance: After the PACIFIC trial, concurrent chemo-radiotherapy followed by consolidation therapy with durvalumab for 1 year (limited to PD-L1 tumour proportion score ≥ 1% in the EMA region) is the...
4.
Stereotactic boost on residual disease after external-beam irradiation in clinical stage III non-small cell lung cancer: mature results of stereotactic body radiation therapy post radiation therapy (SBRTpostRT) study
Parisi S, Ferini G, Lillo S, Brogna A, Chillari F, Ferrantelli G, et al.
Radiol Med . 2023 Jun; 128(7):877-885. PMID: 37294366
Purpose: To evaluate the role of stereotactic body radiation therapy (SBRT) delivered after external-beam fractionated irradiation in non-small-cell lung cancer (NSCLC) patients with clinical stage III A, B. Materials And...
5.
Non-stereotactic radiotherapy in older cancer patients
Parisi S, Lillo S, Cacciola A, Ferini G, Valenti V, Viola A, et al.
Heliyon . 2022 Jun; 8(6):e09593. PMID: 35706953
Old or very old oncological patients represent a heterogeneous and frail population due to concomitant comorbidities. Whether radiotherapy alone or in combination with novel cancer drugs may provide a clear...
6.
Curative Radiotherapy in Elderly Patients With Muscle Invasive Bladder Cancer: The Prognostic Role of Sarcopenia
Ferini G, Cacciola A, Parisi S, Lillo S, Molino L, Tamburella C, et al.
In Vivo . 2021 Jan; 35(1):571-578. PMID: 33402511
Background/aim: To evaluate the impact of sarcopenia in muscle invasive bladder cancer (MIBC) elderly patients submitted to curative radiotherapy. Patients And Methods: Patients received radiotherapy between 2013 and 2018, and...
7.
Vaginal Mucosal Melanoma: a Complete Remission after Immunotherapy and '0-7-21' Radiotherapy Regimen (24 Gy/3 fractions/21 days)
Parisi S, Lillo S, Cacciola A, Santacaterina A, Palazzolo C, Platania A, et al.
Folia Med (Plovdiv) . 2020 Oct; 62(3):605-609. PMID: 33009750
We present the case of a patient with vaginal mucosal melanoma who underwent complete remission after immunotherapy and '0-7-21' radiotherapy regimen (24 Gy/3 fractions/21 days). An 80-year-old woman had a...
8.
Simultaneous Integrated Boost Radiotherapy in Unresectable Stage IV (M0) Head and Neck Squamous Cell Cancer Patients: Daily Clinical Practice
Iati G, Parisi S, Santacaterina A, Pontoriero A, Cacciola A, Brogna A, et al.
Rep Pract Oncol Radiother . 2020 May; 25(3):399-404. PMID: 32368191
Aim: To evaluate clinical outcome in locally-advanced stage IV (M0) head and neck cancer patients treated using intensity-modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) in daily clinical practice. Background:...
9.
Trends in combined radio-chemotherapy for locally advanced rectal cancer: a survey among radiation oncology centers of Sicily region on behalf of AIRO
Spatola C, Privitera G, Milazzotto R, Tocco A, Acquaviva G, Marletta F, et al.
Radiol Med . 2019 Feb; 124(7):671-681. PMID: 30806918
Aim: To conduct a survey among Sicilian centers of radiation oncology belonging to Associazione Italiana di Radioterapia ed Oncologia Clinica (AIRO), to record the different methods of integration of radio-chemotherapy...
10.
Nodal Ratio as a Prognostic Factor in Patients with Four or More Positive Axillary Nodes Treated with Breast-conserving Therapy and Regional Nodal Irradiation
Iati G, Pontoriero A, Mondello S, Santacaterina A, Platania A, Frosina P, et al.
Anticancer Res . 2016 Jun; 36(7):3549-54. PMID: 27354622
Aim: This study aimed to investigate the prognostic value of the axillary lymph node ratio (i.e. positive axillary nodes to nodes removed) in patients with breast cancer treated with conservative...